Utility of the icteric index for the management of bilirubin test requesting

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. The re-emergence of dried blood spot sampling – are we ready?
4. Review
5. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease
6. Opinion Paper
7. Exertional hematuria: definition, epidemiology, diagnostic and clinical considerations
8. Guidelines and Recommendations from Scientific Societies
9. A protocol for testing the stability of biochemical analytes. Technical document
10. Genetics and Molecular Diagnostics
11. Hereditary hyperferritinaemia-cataract syndrome (HHCS) – an underestimated condition: ferritin light chain variant spectrum in German families
12. General Clinical Chemistry and Laboratory Medicine
13. Performance of a web-based application measuring spot quality in dried blood spot sampling
14. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients
15. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study
16. Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease
17. Integrity of serum samples is changed by modified centrifugation conditions
18. Heparin and citrate additive carryover during blood collection
19. Copeptin – a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease
20. Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits
21. Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC
22. Establishment of the intelligent verification criteria for a routine urinalysis analyzer in a multi-center study
23. Reference Values and Biological Variations
24. A new indirect estimation of reference intervals: truncated minimum chi-square (TMC) approach
25. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency
26. Early pregnancy reference intervals; 29 serum analytes from 4 to 12 weeks’ gestation in naturally conceived and uncomplicated pregnancies resulting in live births
27. Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents
28. Hematology and Coagulation
29. Study of the analytical performance at different concentrations of hematological parameters using Spanish EQAS data
30. Multicenter performance evaluation of the Abbott Alinity hq hematology analyzer
31. Cardiovascular Diseases
32. Fast 0/1-h algorithm for detection of NSTEMI: are current high-sensitivity cardiac troponin assays fit for purpose? An EQA-based evaluation
33. Infectious Diseases
34. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis – a pilot study
35. Letters to the Editor
36. Quality management at the national biobanking level – establishing a culture of mutual trust and support: the BBMRI.at example
37. Molecular diagnosis of MODY3 permitted to reveal a de novo 12q24.31 deletion and to explain a complex phenotype in a young diabetic patient
38. Increased C-reactive protein values in the absence of inflammation: monoclonal immunoglobulin interference in immunonephelometry
39. An approach based on simulated hemolysis for establishing the hemolysis index threshold for high-sensitivity cardiac troponin T assay
40. Utility of the icteric index for the management of bilirubin test requesting
41. Quality control of monocyte volume and distribution width parameters of the Beckman Coulter DxH series
42. Mozhaisk haemoglobin variant effects on leukocyte differential channel using the Sysmex XN series
43. Detection of a novel hemoglobin variant Hb Liaoning by matrix assisted laser desorption/ionization-time of flight mass spectrometry
44. Appropriateness of repetitive therapeutic drug monitoring and laboratory turnaround time
45. Congress Abstracts
46. 51^th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)